2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Other: new trials by email Literature Review of Other trials Research Report on Other
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553 D-1553 - Healthy Male | Phase 1 | Completed | InventisBio Co., Ltd | 45 | 2023-05-24 | 2024-10-15 |
| A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer D-1553, Other - NSCLC | Phase 1 / Phase 2 | Terminated | InventisBio Co., Ltd | 22 | 2022-09-13 | 2024-10-15 |
| Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus Other - Type 2 Diabetes Mellitus | Phase 1 | Completed | Institut de Recherches Internationales Servier | 100 | 2017-04-03 | 2024-07-25 |
Cardiovascular Diseases (1) · Diabetes Mellitus, Type 2 (1)
InventisBio Co., Ltd (2) · Institut de Recherches Internationales Servier (1)
China (2) · Germany (1)
2017 (1)